News & Articles

HeartMate 3 offers significant advancements for patients not eligible for a heart transplant

Clinical study results suggest individuals with type I or II diabetes may achieve improved glycaemic control with Tresiba

This intelligent surgical device is a cornerstone in the surgical removal of cancers

The test supports international guidelines for treating antibiotic resistant STI

The National Center for Tumor Diseases and Protagen AG collaborate to improve information integration

Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors

Novel drug, aducanumab, successfully attacks and clears amyloid β protein deposits

How ddPCR technology could enable earlier therapeutic intervention in EGFR mutated lung cancers

People who suffer a stroke caused by bleeding in the brain could be helped by four simple checks of their brain scans, research suggests

Collaborative research effort reduces off-target CRISPR-Cas9 genome editing, removing barriers for human therapeutic applications

Researchers from University of Manchester and Salford Royal NHS Foundation Trust have developed an instrument which could treat chronic ulcers with light

The findings could help clinicians decide the best course and delivery of treatment for cancer patients

New study suggests diagnosis and management of patients with viral meningitis is sub-optimal

Recent findings show initial testing for three specific biomarkers may provide superior results over standard screening methods

NOSO-502 on track to be the first novel antibiotic class to be introduced into the clinics for 40 years

First high-sensitivity troponin I assay available in the United States enables clinicians to provide improvements in cardiac patient management

To be in with a chance of winning a $500 Amazon voucher, cast your vote by July 23

Alphasonics are optimizing new ultrasonic cleaning systems with ProReveal

Fresh insights into a potentially life-threatening lung disease that causes persistent coughing could pave the way for new therapies

Elenbecestat shown to reduce amyloid beta levels in the brain in phase II clinical study